Abstract | BACKGROUND: PATIENTS AND METHODS: In a retrospective study we reviewed 24 patients ranging in age from 62 to 92 years (mean 77 years) with AION. The duration of follow-up was between 8-51 months (mean 24.8 months). All patients received iso- (Hct > 40%) or hypervolemic (Hct < or = 40%) hemodilution over 8-10 days with daily infusion of 10% hydroxyethyl- starch 200/0.5. The hematocrit decreased significant (p < 0.001) from 43.4 +/- 3.8% to 37.8 +/- 3.5% after this 10-day hemodilution treatment. RESULTS: After the longterm follow-up 29.1% of the patients had an improvement of the central vision by two or more lines, 16.7% had a deterioration, 54.2% remained unchanged. The resulting visual acuity was between 0.5-1.0 in 37.5%, between 0.4-0.1 in 41.7% and worse than 0.1 in 20.8%. Neither visual fields nor the VECP were significant changed by hemodilution. After the mean follow-up period of 24.8 months no recurrence occurred in the affected eye and the second eye as never involved. CONCLUSION:
Hemodilution therapy has no significant longterm effect on visual acuity and visual fields, but it seems to have a beneficial influence on the recurrence rate in the affected and on the involvement of the second eye.
|
Authors | A Haas, I Uyguner, G E Sochor, O Schmut, B Vidic, J Faulborn |
Journal | Klinische Monatsblatter fur Augenheilkunde
(Klin Monbl Augenheilkd)
Vol. 205
Issue 3
Pg. 143-6
(Sep 1994)
ISSN: 0023-2165 [Print] Germany |
Vernacular Title | Nichtarteriitische vordere ischämische Optikusneuropathie: Langzeitergebnisse nach Hämodilutionstherapie. |
PMID | 7527879
(Publication Type: English Abstract, Journal Article)
|
Chemical References |
- Hydroxyethyl Starch Derivatives
|
Topics |
- Aged
- Aged, 80 and over
- Evoked Potentials, Visual
(drug effects)
- Female
- Follow-Up Studies
- Hematocrit
- Hemodilution
(methods)
- Humans
- Hydroxyethyl Starch Derivatives
(administration & dosage)
- Ischemia
(blood, etiology, therapy)
- Long-Term Care
- Male
- Middle Aged
- Optic Nerve
(blood supply)
- Optic Neuritis
(blood, etiology, therapy)
- Recurrence
- Retrospective Studies
- Visual Acuity
(drug effects)
- Visual Fields
(drug effects)
|